Gubra AS (FRA:PI3) FFO


FRA:PI3 Gubra AS FRA:PI3
73 GF Score
Price €44.08
GF Value €389.49
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gubra AS FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PI3
73GF Score
Gubra AS FRA:PI3
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gubra AS (FRA:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of €44.08 is trading 88.7% below its estimated GF Value™ of €389.49. GuruFocus considers Gubra AS to be Possible Value Trap.

Key valuation signals for FRA:PI3:

  • FFO:
  • GF Value™: €389.49 vs. price of €44.08 (88.7% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the FRA:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
73GF Score

Get the complete analysis for FRA:PI3

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€44.08
Price
€389.49
GF Value